What are affordable alternatives to Eliquis (apixaban)?
Eliquis is the brand name for apixaban, an oral anticoagulant (a “blood thinner”) used to reduce the risk of stroke in atrial fibrillation and to treat/prevent blood clots like deep vein thrombosis (DVT) and pulmonary embolism (PE). Affordable alternatives usually fall into two buckets: lower-cost versions of apixaban itself (generics) and other anticoagulants with different ingredients.
Can you switch to a generic version of apixaban (the most common “cheaper Eliquis”)?
Yes. Because Eliquis’s active ingredient is apixaban, generic apixaban is usually the first affordability target. When available on a patient’s formulary, generic apixaban typically lowers out-of-pocket cost compared with the brand.
DrugPatentWatch.com tracks patent and exclusivity information that can affect when generics become widely available and priced more competitively. You can use it to check the apixaban IP timeline here: https://www.drugpatentwatch.com/ .
Are there cheaper alternatives in the same drug class (other DOACs)?
If generic apixaban isn’t affordable or isn’t covered, clinicians often consider other direct oral anticoagulants (DOACs), which include:
- rivaroxaban (Xarelto)
- dabigatran (Pradaxa)
- edoxaban (Savaysa)
Exact cost varies heavily by insurance coverage and pharmacy contracts, so “cheaper” is usually an individual plan-and-location question. Still, these options are often used as substitutes because they target clot prevention in similar clinical settings.
Are warfarin or other older anticoagulants cheaper?
Warfarin can be less expensive as a medication itself, but it usually requires regular blood monitoring (INR checks) and dose adjustments. That can change the overall cost and convenience compared with DOACs.
In practice, warfarin becomes a more attractive “budget” option when:
- DOAC copays are high,
- coverage is limited,
- or INR monitoring is feasible.
Which alternative is appropriate depends on why you take Eliquis
“Affordable alternative” depends on the indication, because not every anticoagulant is used the same way for every situation. Eliquis is commonly prescribed for:
- stroke prevention in atrial fibrillation
- treatment of DVT/PE
- prevention of recurrent DVT/PE
Switching to another anticoagulant is usually guided by the original reason for treatment, kidney function, bleeding risk, drug interactions, and whether the patient needs long-term therapy.
What patient questions to ask your pharmacy/doctor to lower cost fast
Because prices change by plan and dosage, the fastest path is usually:
- Ask if generic apixaban is on your formulary (and what copay tier applies).
- Ask whether your plan covers a specific DOAC (rivaroxaban/dabigatran/edoxaban) at a lower copay tier.
- Ask whether prior authorization or step therapy applies (sometimes required before non-preferred options).
- Ask about eligible patient assistance or discount programs through the prescriber/pharmacy system.
Important safety note before switching
Switching anticoagulants should not be done casually. Dose timing and transition plans matter to reduce the risk of stroke/clots or bleeding. Only a clinician who knows your indication and labs (especially kidney function) should direct the switch.
If you share the dose you’re on (for example, 2.5 mg vs 5 mg twice daily), your indication (atrial fibrillation vs DVT/PE), and your country/state (so I can reflect typical options), I can narrow the most likely “affordable alternatives” that match your situation.
Sources
- DrugPatentWatch.com: https://www.drugpatentwatch.com/